Basal Insulin in the Management of Patients With Diabetic Ketoacidosis.

Trial Profile

Basal Insulin in the Management of Patients With Diabetic Ketoacidosis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Dec 2013

At a glance

  • Drugs Insulin; Insulin glargine; Insulin glulisine; Insulin suspension isophane
  • Indications Diabetes mellitus; Diabetic ketoacidosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Dec 2009 Actual number of patients changed from 60 to 74 as reported by ClinicalTrials.gov.
    • 07 Sep 2008 Results presented at the 44th Annual Meeting of the European Association for the Study of Diabetes
    • 19 Aug 2008 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top